Sign In
Buy MDRX
$4.75
+0.250 (+5.56%)
At Close: Jun 03, 2026
Veradigm Inc. (MDRX) Discusses Progress on SEC Filings, Relisting Efforts and Strategic Update Transcript
11:54am, Thursday, 28'th May 2026
Veradigm Inc. (MDRX) Discusses Progress on SEC Filings, Relisting Efforts and Strategic Update Transcript
Veradigm Files 2023 and 2024 Form 10-K
04:10pm, Tuesday, 26'th May 2026
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today the filing of its comprehensive Annual Repor
Veradigm Survey: Independent Practices Rely on Technology to Stay Independent
08:01am, Wednesday, 06'th May 2026
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today released findings from a nationally distributed survey
Veradigm Receives KLAS 2026 Points of Light Award for Embedding SDOH Data in Provider EHR Workflows
04:01pm, Tuesday, 28'th Apr 2026
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced that it has been recognized by KLAS in the 2
Veradigm Doubles India-Based Employee Footprint, Adds New Managing Director
10:31pm, Monday, 27'th Apr 2026
PUNE, India--(BUSINESS WIRE)--Veradigm® India Private Limited, the India subsidiary of Veradigm (OTCMKTS: MDRX), a US-based leader in clinical and revenue cycle solutions for independent practices, t
Veradigm: You Can't Fall Off The Floor
08:50pm, Monday, 27'th Apr 2026
Veradigm trades near 20-year lows after accounting issues, delisting, and management upheaval, but its core business remains fundamentally sound. New management is focused on becoming current with SEC
Veradigm Appoints Christian Greyenbuhl as Chief Financial Officer
04:01pm, Monday, 06'th Apr 2026
CHICAGO--(BUSINESS WIRE)--Veradigm Inc. (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced the appointment of Christian Greyenbuhl as Chie
Veradigm Inc. (MDRX) Discusses Strategic Reset, Product Portfolio Decisions and Growth Initiatives Transcript
12:05pm, Wednesday, 18'th Feb 2026
Veradigm Inc. (MDRX) Discusses Strategic Reset, Product Portfolio Decisions and Growth Initiatives Transcript
Veradigm Provides Business and Strategy Update
04:01pm, Tuesday, 17'th Feb 2026
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, is providing estimated financial performance for the fiscal
Veradigm Brings Patient Voice to Healthcare Research with New Real-World Data Survey Solution
08:01am, Friday, 13'th Feb 2026
CHICAGO--(BUSINESS WIRE)--Veradigm (OTCMKTS:MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced a new patient‑reported outcomes (PRO) survey
Veradigm to Release Business Update February 17th and Host Investor Call February 18th
04:01pm, Tuesday, 10'th Feb 2026
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, announced today that management plans to provide a business
Veradigm Extends Stockholder Rights Plan
04:01pm, Monday, 02'nd Feb 2026
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced that its Board of Directors (the “Board”
Veradigm Launches New AI Application for Powerful Revenue Cycle Insights for Independent Practices
04:01pm, Wednesday, 28'th Jan 2026
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of clinical and revenue cycle solutions for independent practices, today announced the launch of a new AI-enabled application f
Veradigm (NASDAQ:MDRX) Shares Gap Up – What’s Next?
02:14am, Friday, 02'nd Jan 2026
Veradigm Inc. (NASDAQ: MDRX - Get Free Report) gapped up prior to trading on Wednesday. The stock had previously closed at $4.55, but opened at $4.70. Veradigm shares last traded at $4.70, with a volu
Veradigm Launches Enhanced Ambient Scribe Capabilities
08:01am, Monday, 17'th Nov 2025
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, today announced enhancements to the artificial intelligence (AI) enhanced Ambient
